Glioma: A Common Type of Brain Tumor That can be Fatal
- Glioma is a common type of tumor originating in the brain, which is formed in glial cells. Glial cells are cells in the brain, which surround and support neurons in the brain including astrocytes, oligodendrocytes, and ependymal cells.
- Glioma can affect functioning of the brain and it can be fatal, depending on its location and severity of tumor
- Glioma is of different types: astrocytomas, brain stem gliomas, ependymomas, mixed gliomas (oligo-astrocytomas), oligodendrogliomas, and optic pathway gliomas
- Headache; seizures; numbness; weakness in the arms, the face, or the legs; and personality changes are some of the major symptoms observed in patients with glioma
- Risk factors for the development of glioma range from old age (more common in adults between 45-65 years of age) and radiation exposure to family history of glioma
- Various diagnostic methods are available for detection of glioma. Depending on severity of the disease, different types of treatments or therapies are suggested to patients.
Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure of Glioma Diagnosis Market Report
Key Drivers and Restraints of Global Glioma Diagnosis Market
- Advancements in brain tumor diagnosis and growing prevalence of brain cancer are some of the major factors fueling the global glioma diagnosis market
- For instance, as per the American Society of Clinical Oncology (ASCO), around 23,820 adults in the U.S. were diagnosed with primary cancerous tumors of the brain and the spinal cord in 2018. Brain tumors accounted for 85% to 90% of all primary CNS (central nervous system) tumors in the country in the year.
- Combination of most advanced diagnostic scanning techniques and rising awareness regarding various types of brain tumors are some of the major factors responsible for growth of the global glioma diagnosis market
- Moreover, growing human exposure to radiations in recent times is leading to high rate of incidence of the brain cancer. This is another factor driving the global glioma diagnosis market.
Higher Costs of Diagnosis Hamper Global Market
- Cost of diagnosis of the brain tumor is very high and it is unaffordable for patients in several developing countries. This high cost can adversely impact the global glioma diagnosis market.
- Regrowth of tumor after treatment and surgery in several cases and adverse effects of chemotherapy are also projected to hamper the global market for glioma diagnosis during the forecast period
Primary Tumor Type Segment Dominates Global Market
- Based on tumor type, the global glioma diagnosis market can be bifurcated into primary tumors and secondary tumors
- The primary tumors segment can be sub-divided into astrocytomas, ependymomas, brain stem gliomas, oligodendrogliomas, mixed gliomas, and others
- The primary tumors segment dominates the global glioma diagnosis market, as primary tumors are more prevalent across the world
Low-grade Gliomas a Promising Grade Segment
- In terms of grade, the global glioma diagnosis market can be segmented into low-grade gliomas, high-grade gliomas, and recurrent high-grade gliomas
- Low-grade gliomas is expected to be the most lucrative segment in the next few years, due to availability of more treatment options and early detection of tumors of low grade
Looking for Regional Analysis or Competitive Landscape in Glioma Diagnosis Market, Ask for a Customized Report
PET Scan Segment Witnesses Strong Growth
- In terms of diagnosis test, the global glioma diagnosis market can be classified into neurological exams, computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, biopsy, electroencephalography (EEG), and others
- The MRI segment accounted for a major market share in 2018. The PET scans segment is estimated to expand at a high CAGR during the forecast period, owing to better sensitivity and higher rate of precision offered by MRI for glioma diagnosis
Hospitals & Clinics a Dominant End-user Segment
- Based on end-user, the global glioma diagnosis market can be segmented into hospitals & clinics, diagnostic imaging centers, cancer research institutes, and others
- The hospitals & clinics segment dominated the global glioma diagnosis market in 2018, owing to the large number of admissions of cancer patients at hospitals and availability of advanced equipment at hospitals and clinics
North America to Lead Global Market for Glioma Diagnosis
- In terms of region, the global glioma diagnosis market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global glioma diagnosis market in 2018, due to high prevalence of brain tumor in the region, growing radiation exposure, and availability of advanced diagnostic devices in the region
- Asia Pacific is likely to be a more promising market for glioma diagnosis in the next few years, due to large geriatric population, the large number of patients with cancer, and rise in awareness regarding diseases and their diagnosis in the region. As per a study published by NCBI in September 2011, the rate of prevalence of primary brain tumors in China was 24.56 per 100,000 people in 2006.
Key Manufacturers Operating in Global Market
Key manufacturers operating in the global glioma diagnosis market are:
- GE Healthcare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Shimadzu Corporation
- Hitachi Medical Corporation
- Fujifilm Holdings Corporation
- Carestream Health
- Hologic, Inc.
- CANON MEDICAL SYSTEMS CORPORATION
- ESAOTE SPA
Global Glioma Diagnosis Market: Research Scope
Global Glioma Diagnosis Market, by Tumor Type
- Primary Tumors
- Brain Stem Gliomas
- Mixed Gliomas
- Secondary Tumors
Global Glioma Diagnosis Market, by Grade
- Low-grade Gliomas
- High-grade Gliomas
- Recurrent High-grade Gliomas
Global Glioma Diagnosis Market, by Diagnosis Test
- Neurological Exams
- Computed Tomography (CT) Scan
- Magnetic Resonance Imaging (MRI)
- Positron Emission Tomography (PET) Scan
- Electroencephalography (EEG)
Global Glioma Diagnosis Market, by End-user
- Hospitals & clinics
- Diagnostic Imaging Centers
- Cancer Research Institutes
Global Glioma Diagnosis Market, by Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.